We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Impact of Nanoplastic Particles on Intestinal Epithelium Health Using a Vascularized Gut-on-aChip Model
Summary
Researchers developed a vascularized gut-on-a-chip model to evaluate how nanoplastics affect intestinal health, focusing on bioaccumulation, translocation across epithelial barriers, and immune responses at the gut-blood interface — a more physiologically realistic platform than conventional cell culture approaches.
Nanoplastics (NPLs), small plastic particles formed from the environmental breakdown of larger plastics, are known bioavailable contaminants. Their size enables them to cross biological barriers, interact with epithelial and immune cells, and transport toxic additives and biofilm-forming microbes. These properties highlight the urgent need to understand their effects on human health, particularly in the gastrointestinal tract (GI), a primary site of exposure through ingestion. Despite mounting evidence linking NPLs to health issues like immune response and inflammation, their impact on gut health using physiologically relevant models remains poorly characterised. The objective of the project is to develop a novel proof-of-principle gut-on-chip model to evaluate the impact and toxicity of NPLs on gut health, focusing on bioaccumulation, translocation, and barrier integrity at the endothelium, epithelium, mucus and immune interface.